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The Vesicle Docking Protein p115 Binds GM130,
a cis-Golgi Matrix Protein,
in a Mitotically Regulated Manner
Nobuhiro Nakamura,* Martin Lowe,* are larger in size than those generated by the COPI-
dependent pathway.Timothy P. Levine,² Catherine Rabouille,
and Graham Warren³ The mitotic mechanism that prevents docking and
fusion of vesicles generated by the first pathway hasCell Biology Laboratory
Imperial Cancer Research Fund proved elusive. During interphase, the docking of the
vesicles with the correct membrane is thought to be44 Lincoln's Inn Fields
London WC2A 3PX mediated by SNAREs (Rothman and Wieland, 1996). A
v-SNARE on the vesicle recognizes the cognate t-SNAREUnited Kingdom
on the target membrane. The formation of this complex
is regulated by the Ypt/rab family of small GTP-binding
proteins (Nuoffer and Balch, 1994). Correct pairing isSummary
followed by thebinding of the fusion machinerycompris-
ing SNAPs and the NSF ATPase. Hydrolysis of ATPThe docking of transport vesicles with their target
breaks up the SNARE complex and somehow leads tomembrane is thought to be mediated by p115. We
membrane fusion.show here that GM130, a cis-Golgi matrix protein, in-
We focused our attention on p115, which was firstteracts specifically with p115 and so could provide a
identified as a component needed for intra-Golgi trans-membrane dockingsite. Deletion analysis showed that
port (Waters et al., 1992). Cloning and sequencingthe N-terminus binds to p115, whereas the C-terminus
showed that it was identical to TAP, a protein involvedbinds to Golgi membranes. Mitotic phosphorylation
in transcytotic membrane traffic (Barroso et al., 1995),of GM130 or a peptide derived from the N-terminus
and homologous to Uso1p, a yeast protein essential forprevented binding to p115. The peptide also inhibited
ER-to-Golgi traffic (Nakajima et al., 1991). Uso1p actsthe NSF- but not the p97-dependent reassembly of
before the hydrolysis of ATP leading to vesicle fusionGolgi cisternae from mitotic fragments, unless it was
(Lupashin et al., 1996), and even before the formationmitotically phosphorylated. Together, these data pro-
of the ER±Golgi SNARE complexes (Sapperstein et al.,vide a molecular explanation for the COPI-mediated
1996). It is in fact needed to form them, acting alongsidefragmentation of the Golgi apparatus at the onset of
(or just before) Ypt1p (Sapperstein et al., 1996). Themitosis.
likely function is in vesicle docking. Overexpression of
certain SNAREsrescues the lethal phenotype of mutants
Introduction deleted for Uso1p. This is most readily explained as a
mass action effect, the decreased efficiency of vesicle
Of all the membrane-bound organelles in the animal docking being compensated by higher levels of the pro-
cell, the Golgi apparatus undergoes the most dramatic teins that stabilize the docked state (Sapperstein et al.,
transformation at mitosis. The ribbon of linked Golgi 1996). Furthermore, TAP/p115 has been shown to bind
stacks in the juxtanuclear region is replaced by discrete transcytotic vesicles to apical plasma membranes in
clusters of vesicles and tubules that become distributed the absence of ATP (Barroso et al., 1995). Finally, the
throughout the mitotic cytoplasm in preparation for divi- structure of p115/Uso1p is consistent with a docking
sion of the mother cell into two daughters. Conversion function. Rotary shadowing reveals a myosin-shaped
of cisternal stacks into vesicles and tubules has been molecule with two globular heads linked by a long tail,
studied in detail both in vivo and in vitro using cell-free the length of which is comparable to or greater than the
systems that mimic the process (Warren, 1993). The width of a transport vesicle (Sapperstein et al., 1995;
following picture emerges from these studies. Yamakawa et al., 1996). It would be easy to imagine
Fragmentation occurs by two distinct but temporally such a large molecule tethering transport vesicles to
overlapping processes (Warren et al., 1995). The first potential target membranes.
involves the continued budding of COPI-coated vesicles The affinity of p115 for Golgi membranes decreases
from the cisternal rims. These transport vesicles uncoat, 20-fold when membranes are treated with mitotic (but
but whereas they would normally dock and fuse with
not interphase) cytosol (Levine et al., 1996). This effect
their target membrane, under mitotic conditions they
is reversible and appears to be mediated by cyclin-
cannot and accumulate as small z50 nm diameter vesi-
dependent kinases. Higher levels of p115 are also found
cles. In vitro, this process can consume up to 65% of
in cytosols isolated from mitotic when compared to in-
Golgi membrane. The rest of the Golgi membrane is
terphase cells (Levine et al., 1996). Finally, after mitotic
consumed by a second pathway that is less well charac-
disassembly of Golgi stacks in vitro, the isolated frag-
terized. Cisternae become increasingly fenestrated,
ments have no bound p115, and p115 has to be added
forming tubular networks that fragment generating a
(together with NSF and a- and g-SNAPs) to permit re-
heterogeneous population of tubules and vesicles that
growth of Golgi cisternae (Rabouille et al., 1995). Taken
together, these data argue that p115 does not bind Golgi
membranes under mitotic conditions. If p115 cannot*The first two authors contributed equally to this work.
bind, it cannot carry out its docking function. This would²Present address: MRC LMB, Hills Road, Cambridge CB2 2QH, U. K.
³To whom correspondence should be addressed. prevent the downstream fusion events from occurring.
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Figure 1. Binding of Golgi Proteins to p115
Triton X-100-solubilized Golgi membranes were incubated with ei-
ther control beads or beads containing bound biotin-p115. Total
Golgi extract (lanes 1 and 4, 20% of total) and proteins bound to
control (lanes 2 and 5) or p115 beads (lanes 3 and 6) were fraction-
ated by SDS±PAGE on a 6% gel and visualized by Coomassie stain-
ing (CBB; left panel) or Western blotted with polyclonal antibodies
to GM130 (right panel). Molecular mass markers are shown in kDa.
These biochemical experiments also showed that the
target for mitotic inhibition was not p115 but the binding Figure 2. p115 Binds Directly to GM130
sites on Golgi membranes (Levine et al., 1996). We have (A) Golgi membranes (20 mg; lanes 1, 4, and 7), carbonate-washed
now identified one of these binding proteins as GM130, (CW) Golgi membranes (20 mg; lanes 2, 5, and8), and immunoprecip-
itated (IP) GM130 (z100 ng; lanes 3, 6, and 9) were fractionated byoriginally characterized as a Golgi matrix protein of 130
SDS±PAGE on a 6%±15% gel and either stained with CoomassiekDa (Nakamura et al., 1995). Extraction of Golgi mem-
blue (CBB; left panel), Western blotted with a monoclonal antibodybranes with Triton X-100 in low salt leaves behind a
against GM130 (middle panel), or far Western blotted with biotin-
matrix of proteins with a morphology often reminiscent p115 (right panel). The arrow to the right of lane 3 (left panel) refers
of Golgi stacks (Slusarewicz et al., 1994). GM130 is a to the position of immunoprecipitated GM130. The IgG heavy (H)
component of this matrix, and the sequence predicts and light (L) chains are also marked. Molecular mass markers are
shown in kDa.coiled-coil domains throughout the central region, sug-
(B) Golgi membranes (10 mg; lanes 1, 4, and 7), purified p115 (280gesting a jointed rod-like protein. It belongs to an in-
ng; lanes 2, 5, and 8), and a bacterial extract containing truncatedcreasingly large family of proteins thought tobe involved
p115 (28 mg; lanes 3, 6, and 9) were fractionated by SDS±PAGE on
in structural maintenance of the Golgi stack (Nakamura a 6% gel and either stained with Coomassie blue (CBB; left panel),
et al., 1995). Western blotted with antibodies against p115 (middle panel), or far
Western blotted with 35S-labeled GM130 (right panel). Molecular
mass markers are in kDa.Results
p115 Binds to GM130
Purified p115 was biotinylated, bound to streptavidin (Nakamura et al., 1995). As such, it was in a suitable
position to tether transport vesicles to Golgi membranesbeads, and incubated with a Triton X-100 extract of rat
liver Golgi membranes. After washing the beads, bound via p115. Second, we found that this protein bound to
p115 in a mitotically regulated manner (see below). Asproteins were eluted with buffer containing 0.5 M KCl,
fractionated by SDS±PAGE, and visualized by Coomas- such, it could help explain Golgi fragmentation through
mitotic inhibition of vesicle docking.sie staining.
As shown in Figure 1 (left panel), control beads bound To demonstrate a direct interaction between p115
and GM130 and not one mediated by p400, far Westerna protein of 66 kDa, most likely rat serum albumin, as
well as a few minor proteins in the 45±60 kDa range. blotting was performed. Golgi proteins were fraction-
ated by SDS±PAGE (Figure 2A) and either Coomassiep115 beads bound, in addition, two major proteins of
130 kDa and z400 kDa. We focused on p130 protein stained (Figure 2A, left panel), Western blotted with anti-
bodies to GM130 (Figure 2A, middle panel), or overlaidfor two reasons. First, Western blotting identified it as
GM130 (Figure 1, right panel), a tightly bound peripheral with biotin-p115, which was visualized using HRP-con-
jugated streptavidin (Figure 2A, right panel). Biotin-p115protein on the cytoplasmic side of Golgi membranes
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bound to a protein (Figure 2A, lane 7) with the same residues upstream of the original predicted start site.
Further sequencing using the RACE protocol revealedmolecularweight as that recognizedby anti-GM130 anti-
bodies (Figure 2A, lane 4; the lower molecular weight another ATG 12 amino acids further upstream. To deter-
mine which of these two start codons was actually usedband is a proteolytic degradation product of GM130).
Binding was abolished by prior treatment of Golgi mem- in vivo, GM130 was translated in vitro from each of these
two upstream start codons, and the size of the productbranes with sodium carbonate (Nakamura et al., 1995),
conditions that remove peripheral Golgi proteins includ- compared with that of the native protein by SDS±PAGE.
Translation from the first ATG yielded a product that wasing GM130 (Figure 2A, lanes 2, 5, and 8). Specific binding
to GM130 was confirmed by immunoprecipitating larger, while translation from the second ATG yielded a
product with exactly the same molecular weight (dataGM130 from a detergent extract of Golgi membranes.
The purified protein was visible by Coomassie staining not shown). Since this second ATG was present in
the original rat cDNA, the molecular weight and hence(Figure 2A, lane 3, arrow), together with the heavy and
light chains of the antibody (oligomers of which were the designation of the protein as GM130 remains un-
changed. The predicted sequence of the new N-termi-also present near the top of the gel). This protein was
specifically labeled with antibodies to GM130 (Figure nus is shown in Figure 3A, and the complete sequence
is available under GenBank accession number U35022.2A, lane 6) and recognized by biotin-p115 (Figure 2A,
lane 9). The minor band labeled by biotin-p115 is the The binding site for p115 on GM130 was mapped by
deletion analysis. A series of N-terminal and C-terminalabundant antibody heavy chain (cf. Figure 2A, lanes 3
and 9). Other weaker labeling of proteins in Golgi ex- truncation mutants were constructed, and these are de-
tailed in Figure 3B. They were expressed as 35S-labeledtracts revealed no consistent pattern between experi-
ments (Figure 2A, lanes 7 and 8). p400 (Figure 1) was proteins by in vitro transcription/translation and then
incubated with p115 beads or beads alone. Bound andnot detected either because of poor transfer to the nitro-
cellulose or poor renaturation. unbound proteins werethen fractionated by SDS±PAGE,
and the gel fluorographed. A summary of the results isThe converse experiment was also carried out using
35S-labeled GM130 as the far Western probe. This was provided in Figure 3B, and a selection of the experimen-
tal data is presented in Figure 4A. The full-length proteinprepared by in vitro transcription/translation of the
cDNA for GM130, and it recognized two proteins in frac- and the C-terminal deletions all bound to the p115
beads. Binding was typically 70%±80% of the total fortionated rat liver Golgi membranes (Figure 2B, lane 7).
The upper protein of 130 kDa is GM130 (data not shown), the full-length and DC436, and about 50% for DC237.
Binding to the beads was dependent on the presenceconsistent with our earlier studies showing that GM130
can form oligomeric complexes in detergent with a mo- of p115, since neither the full-length protein nor any of
the constructs bound to beads alone (Figure 4A, laneslecular mass in excess of 1 MDa by gel filtration (Naka-
mura et al., 1995). The lower protein had a molecular 11±14, and data not shown).
In contrast, none of the N-terminal truncations boundweight identical to that of p115, revealed by Western
blotting (Figure 2B, lane 4). Binding to p115 was con- to the p115 beads (Figures 4A and 3B). Even removal
of the first 74 amino acids from GM130 completely abol-firmed in two ways. The first was to purify p115 to near
homogeneity (Figure 2B, lane 2) and show that this pro- ished binding (Figure 4A, DN75, lanes 3 and 4). To con-
firm the role played by the N-terminus of GM130 in p115tein, recognized by anti-p115 antibodies (Figure 2B, lane
5), was also recognized by 35S-labeled GM130 (Figure binding, a peptide corresponding to this region was
synthesized (N73pep; see Figure 3A). Since the se-2B, lane 8). The second was to express p115 in bacteria
so as to eliminate any possibility that GM130 was bind- quence predicts removal of the start methionine and
acetylation of the exposed serine (Moerschell et al.,ing to a protein with the same molecular weight as p115.
A truncated form of p115 was used, which lacked most 1990), the peptide was synthesized with acetylated ser-
ine at the N-terminus. As shown in Figure 4B, increasingof the globular head. The lysed bacterial extract was frac-
tionated by SDS±PAGE (Figure 2B, lane 3), the position concentrations of this peptide prevented the binding of
full-length GM130 to p115 beads (Figure 4B, lanes 2±5).of the truncated p115 located by Western blotting (Fig-
ure 2B, lane 6), and it was shown to comigrate with the An 80% inhibition was seen at a 17-fold molar excess
band revealed by the far Western probe, i.e., 35S-labeled of peptide over p115 on the beads (Figure 4B, lane 2).
GM130 (Figure 2B, lane 9). The lower molecular weight Several control peptides derived from p115 and syn-
protein recognized by anti-p115 antibodies (Figure 2B, taxin-5 had no effect. An example is shown in Figure
lane 6) is a proteolytic fragment that weakly binds to 4B, lane 6.
GM130 (Figure 2B, lane 9). No binding was observed These results establish the binding of p115 to the
using lysates from bacteria expressing the vector alone N-terminal region of isolated GM130, but they do not
(data not shown). show that the same binding would occur on intact mem-
branes. To address this, we have used an established
in vitro assay to measure binding of p115 to Golgi mem-The N-Terminus of GM130 Binds p115
When the predicted sequence of the human GM130 branes (Levine et al., 1996). p115 was incubated with
increasing concentrations of the GM130 N-terminal pep-(Y. Misumi and Y. Ikehara, unpublished data) was com-
pared with that of the rat sequence we originally cloned, tide, and its binding to Golgi membranes quantitated.
Preincubation of p115 with a 50-fold excess of N73pepan N-terminal extension was found in the human se-
quence. This prompted us to reexamine the rat cDNA inhibited binding to Golgi membranes by 60%±70%,
while control peptides had no significant effect (Fig-sequence, and a sequencing error was found that re-
vealed a new in-frame start codon (ATG) 74 amino acid ure 4C). In addition, polyclonal antibodies were raised
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Figure 3. Structure of GM130 and Truncation
Constructs
(A) The N-terminus of rat GM130. Note the
putative cyclin-dependent kinase phosphor-
ylation sites (boxed) and the net positive
charge. The sequence in bold was used to
synthesize an N-terminal peptide (N73pep).
(B) Schematic representation of the GM130
secondary structure and the deletion mutants
used in this analysis. There are six predicted
coiled-coil domains (boxed) in thecentral part
of GM130 that are separated by spacer se-
quences. The proline-rich sequence between
domains 2 and3 mayserve as a flexible hinge.
Deletion mutants were designed taking this
putative domain structure into account. The
number of each construct corresponds to the
position of the first (DN series) or last (DC
series) amino acid residue in full-length
GM130. Shaded boxes indicate an optional
Myc tag. A summary of the binding experi-
ments (see Figures 4 and 5) is shown on the
right. Rabbit antibodies were raised to the
fragments indicated (double-headed arrows).
against N73pep, and their effect on p115 binding was protein could be distinguished from the endogenous
GM130 after transient expression in NRK cells. Themeasured. As shown in Figure 4D, these anti-peptide
antibodies inhibited binding by about 60%, while preim- cDNAs were microinjected directly into the nucleus, in-
cubated, and then fixed, permeabilized, and double la-mune antibodies had no effect.
beled. The results are summarized in Figure 3B, and
some of the data is presented in Figure 5.The C-Terminus of GM130 Binds
Golgi Membranes The full-length GM130 localized to a compact juxta-
nuclear reticulum (Figure 5A) characteristic of the GolgiThe same series of truncation constructs (Figure 3B)
was used to determine which part of GM130was respon- apparatus. This was confirmed by double labeling for
the medial and trans marker Mannosidase II (data notsible for the tight binding to Golgi membranes. A Myc
tag was placed at the N-terminus so that the expressed shown). The expressed protein could be distinguished
Figure 4. The N-Terminus of GM130 Binds
p115
(A) N- and C-terminal truncations of GM130
(see Figure 3B) were constructed and ex-
pressed as 35S-labeled proteins by in vitro
transcription/translation. Beads with (lanes
1±10) or without (lanes 11±14) bound biotin-
p115 were incubated with these labeled pro-
teins and the bound (``B'') and unbound (``U'')
fractions were resolved by SDS±PAGE on an
8% gel and detected by fluorography.
(B) In vitro-translated 35S-labeled full-length
GM130 was incubated with p115 beads in
the absence or presence of increasing con-
centrations of GM130 N-terminal peptide
(N73pep; at 0.5, 1.5, 5, and 15 mM, corre-
sponding to a 17, 50, 170, and 500 molar ex-
cess over p115, respectively; lanes 2±5) or a
control peptide corresponding to amino
acids 907±919 of p115 (p115.4, added at a
500 molar excess over p115; lane 6). Bound
GM130 was detected by fluorography.
(C) p115 was preincubated in the absence
(none) or presence of a 15- or 50-fold molar
excess of N73pep or control peptide (p115.4).
Salt-washed Golgi membranes were added,
and bound p115 detected by immunoblotting
and quantitated. Results are expressed as
the mean 6 SEM (n 5 4).
(D) Salt-washed Golgi membranes were preincubated with or without preimmune antibodies (PI) or anti-N73pep antibodies. p115 was added,
the membranes reisolated, and bound p115 detected by immunoblotting and quantitated. Results are expressed as the mean of two experi-
ments, the error bar showing the range.
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Figure 5. Localization and Effect on p115 of GM130 Constructs and N73pep
Left gallery: binding to Golgi membranes. Full-length and N-terminal truncations of GM130 were tagged with the Myc epitope (A±C and E±G)
or GFP (D and H) and transiently expressed in NRK cells. Cells were processed and double labeled with antibodies to the Myc tag (A±C) and
the 97 kDa fragment of GM130 (E±G), or labeled with anti-N73pep antibodies (H).
Middle gallery: effect on endogenous GM130. N-terminal and C-terminal truncation mutants tagged with the Myc epitope were overexpressed
in NRK cells. Cells were processed and double labeled with antibodies to the Myc tag (I±K) and to the 17 kDa fragment of GM130 (L±N).
Right gallery. Effect on p115. Transfected cells (O±Q and S±U), as for the middle gallery, were processed and double labeled with antibodies
to the Myc tag (O±Q) and p115 (S±U). N73pep (R and V) was microinjected into the cytoplasm of NRK cells, which were processed and double
labeled with a monoclonal antibody against GM130 (R) and polyclonal anti-p115 antibodies (V). An asterisk marks the injected cell. Bar 5 25 mm.
from theendogenous protein by the Myc epitope, but the endogenous GM130 (Figure 5H). Second, the endoge-
nous pattern of GM130 was disrupted in NRK cells over-converse was not truebecause theanti-GM130 antibody
used (anti-97 kDa fragment) was against a stretch of expressing the DN690 construct (Figures 5I and 5L),
consistent with the truncated mutant displacing the en-polypeptide found in both proteins. Nevertheless, the
fact that the patterns overlapped almost exactly (cf. dogenous protein. Overexpression did not significantly
affect the structure of the Golgi complex, as judged byFigures 5A and 5E) suggests that the expressed protein
localized to the same place as the endogenous GM130, Mannosidase II staining (data not shown).
C-terminal deletion mutants confirmed these results.namely the cis-Golgi.
Removal of nearly half the N-terminus had little if any Overexpression of constructs lacking the C-terminalhalf
(DC436) or more (DC237) of GM130 had no effect on theeffect on the targeting of GM130 (Figure 5B). This in-
volved removal of the first two coiled-coil domains pre- distribution of endogenous GM130 (Figures 5M and 5N).
Together, these data argue that the C-terminal third ofdicted from the sequence up to the proline-rich region
(construct DN441). Further deletion of coiled-coil do- GM130 is important for Golgi binding and that binding
is enhanced by the coiled-coil domain 3 predicted frommain 3 (construct DN690) led to cytoplasmic accumula-
tion of the truncated protein and weaker binding to the the sequence.
The distribution of p115 was also examined in tran-Golgi apparatus (Figure 5C). Golgi binding was con-
firmed using two approaches. First, the DN690construct siently transfected NRK cells (Figure 5, right gallery).
p115 in untransfected cells is located on the Golgi appa-was tagged with a very sensitive green fluorescent pro-
tein (Cormack et al., 1996). As shown in Figure 5D, the ratus and in the cytoplasm (Sapperstein et al., 1996).
Overexpression of DN690 reduced p115 binding to thereticular staining pattern colocalized exactly with that
obtained using an antibody that only recognized the Golgi apparatus (Figure 5S), consistent with the fact that
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it lacks the p115 binding site found on the endogenous
GM130, which itappears todisplace. Conversely, DC436
and DC237 have the p115 binding site but are unable
to bind to Golgi membranes. These cytosolic constructs
likely compete with endogenous GM130 for p115, ex-
plaining the reduced levels of Golgi-bound p115 (Figure
5T and 5U). Similar results were also obtained by mi-
croinjecting the soluble N-terminal peptide into the cyto-
plasm (Figure 5V), arguing strongly that the N-terminus
of GM130 binds to p115 in vivo as well as in vitro.
GM130 Is Modified under Mitotic Conditions
The binding site for p115 on Golgi membranes was ear-
lier shown to be the target for mitotic modification (Le-
vine et al., 1996). If GM130 is the mitotic target, then
it would be expected to undergo modification during
Figure 6. Mitotic Modification of GM130 and N73pepmitosis.
(A) Golgi membranes were left untreated (``C'', lane 1) or treated forGolgi membranes were incubated with cytosol under
10 min at 378C as follows: interphase cytosol (``I'' lane 2); mitotica variety of conditions, the membranes reisolated, and
cytosol (``M'', lane 3); mitotic cytosol pretreated with 25 mM stauro-the proteins fractionated by SDS±PAGE and Western
sporine (``M1St'' lane 4); treated with mitotic cytosol, then reisolated
blotted for GM130. As shown in Figure 6A, incubation and treated again with interphase cytosol (``M-Rev'' lane 5); mitotic
with interphase cytosol had no effect on the mobility of cytosol pretreated with 1 mM olomoucine (``M1Olo'', lane 6). Golgi
GM130 when compared with control untreated mem- proteins were then fractionated by SDS±PAGE on a 6% gel and
Western blotted with polyclonal antibodies to GM130. The lowerbranes (Figure 6A, lanes 1 and 2). Incubation with mitotic
band is a degradation product of GM130.cytosol, however, had a marked effect on the mobility,
(B) Whole cell extracts from interphase (``I'', lane 1), mitotic (``M'',increasing the apparent molecular mass by about 5 kDa
lane 2), or G1 phase (``G1'', lane 3) HeLa cells were fractionated
(Figure 6A, lane 3). This increase was prevented by prior by SDS±PAGE on a 6% gel and Western blotted with polyclonal
treatment of the mitotic cytosol with the general kinase antibodies to GM130. The percent mitotic index was calculated by
inhibitor, staurosporine (Figure 6A, lane 4), or specific fluorescence microscopy using Hoechst 33258.
(C) Golgi membranes were incubated for 10 min at 378C with in-inhibitors of cyclin-dependent kinases, olomoucine (Fig-
terphase (``I'') or mitotic (``M'') cytosol in the presence of [g-32P]ATP.ure 6A, lane 6) and roscovitine (data not shown) (Meijer,
After solubilization in SDS and immunoprecipitation with either con-1996). The increase was also reversible, since subse-
trol (lanes 1 and 2) or specific antibodies against GM130 (lanes
quent incubation of the mitotically modified membranes 3 and 4), proteins were resolved on a 6% gel and visualized by
with interphase cytosol lowered the mobility to the origi- autoradiography.
nal control levels (Figure 6A, lane 5). (D) Interphase (``I''), mitotic (``M''), or mitotic cytosol plus 25 mM
staurosporine (``M1St'') was incubated with or without the N73pepMitotic modification of GM130 was also observed in
for 30 min at 378C in the presence of [g-32P]ATP. Labeled proteinsvivo (Figure 6B). GM130 extracted from prometaphase
were detected following SDS±PAGE on a 16% Tris±Tricine gel andHeLa cells (arrested using nocodazole; Stuart et al.,
autoradiography. Molecular mass markers are in kDa.
1993) had an apparent molecular mass about 5 kDa
larger (Figure 6B, lane 2) than that in an asynchronous
Mitotically Modified GM130 and the N-Terminalpopulation (Figure 6B, lane 1) and one from which noco-
Peptide Do Not Bind to p115
dazole had been removed and the cells allowed to enter
Mitotic phosphorylation of GM130 and, in particular, theG1 for 7 hr (Figure 6B, lane 3).
N-terminal p115 binding site, suggested the possibility
Since the mitotic state is associated with increased
that binding was mitotically regulated. Golgi membranes
phosphorylation, and the increase in molecular weight
were preincubated with cytosol under a variety of in-
of GM130 was prevented by kinase inhibitors (Figure
terphase and mitotic conditions, and the membranes
6A), the phosphorylation state of GM130 was examined. solubilized with Triton X-100 and incubated with p115
Golgi membranes were incubated with interphase or beads. All treatments after preincubation with cytosols
mitotic cytosol in the presence of [g-32P]ATP, and GM130 were carried out in the presence of staurosporine and
was immunoprecipitated from the detergent-solubilized microcystin. Staurosporine minimizes phosphorylation
membranes. Only the mitotic form of GM130 was phos- during subsequent incubations (such as the p115 on the
phorylated (Figure 6C, lane 4). beads), and microcystin minimizes dephosphorylation
The N-terminal peptide of GM130 was also incubated of modified proteins. The effect is to freeze the phos-
with cytosol in the presence of [g-32P]ATP (Figure 6D). phorylation state of the sample (see Levine et al., 1996).
The peptide was heavily phosphorylated under mitotic Proteins bound to the p115 beads were then fraction-
(Figure 6D, lane 4) but not interphase (Figure 6D, lane ated by SDS±PAGE and Western blotted for GM130.
2) conditions, and mitotic phosphorylation was inhibited The results presented in Figure 7A show that GM130
by staurosporine (Figure 6D, lane 6). Mitotic phosphory- incubated with interphase cytosol bound to p115 beads
lation increased the apparent molecular mass by 1±2 to the same extent as control untreated membranes
kDa, less than that observed for GM130 (z5 kDa). This (Figure 7A, lanes 1 and 2). In marked contrast, almost
either represents phosphorylation elsewhere in the pro- none of the mitotically modified GM130 was bound (Fig-
ure 7A, lane 3). Binding was restored if the mitoticallytein or anomalous migration on SDS gels.
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treated Golgi membranes were incubated with inter-
phase cytosol before solubilization and fractionation
(Figure 7A, lane 5). GM130 also bound if the mitotic
cytosol was pretreated with either staurosporine (Figure
7A, lane 4) or olomoucine (Figure 7A, lane 6) before
being used to treat Golgi membranes.
To eliminate any remaining possibility that the effects
seen were the consequence of mitotic modification of
the p115 on the beads and not the GM130, p115 beads
were pretreated with interphase or mitotic cytosol be-
fore incubation with Triton X-100 extracts of Golgi mem-
branes. As shown in Figure 7B, the same amount of
GM130 bound irrespective of the pretreatment used.
To determine if modification of the GM130 N-terminus
is important for regulating the interaction with p115,
the GM130 N-terminal peptide was bound to beads,
pretreated under various conditions, and binding of
p115 to the beads monitored (Figure 7C). Untreated pep-
tide beads bound p115 (Figure 7C, lane 1), as did beads
pretreated with interphase cytosol (Figure 7C, lane 2) or
mitotic cytosol inactivated with staurosporine (Figure
7C, lane 4). The mitotically modified peptide beads
bound almost no p115 (Figure 7C, lane 3).
The modified peptide was also used to compete with
the binding of 35S-labeled GM130 to p115 beads (see
Figure 4B). As shown in Figure 7D, the binding of 35S-
labeled GM130 (Figure 7D, lane 1) was reduced by un-
treated peptide (Figure 7D, lane 2) and peptide pre-
Figure 7. Mitotic Modification of GM130 or N73pep Prevents Bind- treated with interphase (Figure 7D, lane 3) or mitotic
ing to p115 cytosol inactivated by staurosporine (Figure 7D, lane 5).
(A) Golgi membranes were left untreated (``C'', lane 1) or pretreated The binding was barely affected by peptide pretreated
for 10 min at 378C as follows: interphase cytosol (``I'', lane 2); mitotic
with mitotic cytosol (Figure 7D, lane 4).cytosol (``M'', lane 3); mitotic cytosol pretreated with 25 mM stauro-
Similar results were obtained when binding of p115sporine (``M1St'', lane 4); treated with mitotic cytosol, then reiso-
lated and treated for 10 min at 378C with interphase cytosol to Golgi membranes was analyzed. The peptide was
(``M-Rev'', lane 5); mitotic cytosol pretreated with 1 mM olomoucine added to mitotic or inactivated mitotic cytosol at a 50-
(``M1Olo'', lane 6). Membranes were reisolated, solubilized with fold excess over endogenous p115, and, after preincu-
Triton X-100 in the presence of staurosporine and microcystin, and bation, the ability of the peptide to inhibit binding of
incubated with p115 beads. GM130 bound to the beads was de-
cytosolic p115 to Golgi membranes was analyzed. Pep-tected by Western blotting with polyclonal anti-GM130 antibodies.
tide pretreated with inactivated cytosol inhibited binding(B) p115 beads were left untreated (``C'', lane 1) or treated for 10
min at 378C with interphase (``I'', lane 2) or mitotic (``M'', lane 3) by 50% (Figure 7E), similar to the 60% obtained using
cytosol. After washing with buffers containing staurosporine and untreated peptide (Figure 4C). Pretreatment with mitotic
microcystin, the p115 beads were incubated with Triton X-100 ex- cytosol rendered the peptide incompetent for inhibition
tracts of Golgi membranes in the continued presence of stauro- of p115 binding.
sporine and microcystin. Bound proteins were fractionated by SDS±
PAGE and Western blotted with polyclonal antibodies to GM130.
The N-Terminal Peptide of GM130 Prevents(C) N73pep beads were preincubated in buffer alone (``C''), in-
terphase (``I''), mitotic (``M''), or mitotic cytosol plus 25 mM stauro- Mitotic Reassembly In Vitro
sporine (``M1St'') for 30 min at 378C. After washing in buffer con- The biochemical data provide strong evidence that p115
taining 1 M KCl, the beads were incubated with p115, and bound binds to GM130 in a mitotically regulated manner. Fur-
protein detected by Coomassie blue staining. thermore, this regulated binding can be mimicked by
(D) 35S-labeled GM130 was incubated with p115 beads in the ab-
the N-terminal 73 amino acids of GM130.sence (lane 1) or presence of N73pep (50-fold molar excess of over
The functional significance of this regulated bindingp115), which had been preincubated with either buffer alone (``C'',
was demonstrated using a cell-free assay that reassem-lane 2), interphase (``I'', lane 3), mitotic (``M'', lane 4), or mitotic
cytosol plus 25 mM staurosporine (``M1St'', lane 5). GM130 bound bles the Golgi apparatus from mitotic Golgi fragments
to the beads was detected by fluorography. prepared by incubating Golgi stacks with mitotic cyto-
(E) Mitotic cytosol was preincubated for 30 min at 378C with (1) or sol. After salt washing, the fragments were incubated
without (2) N73pep (at a 50-fold molar excess over p115) in the
with NSF, a- and g-SNAPs, and p115, conditions thatpresence (mitotic 1 St) or absence (mitotic) of 25 mM staurosporine.
result in the regrowth of single cisternae. In the absenceSalt-washed Golgi membranes were then added, incubated for 10
of p115, no regrowth occurs (Rabouille et al., 1995).min at 48C, and reisolated by centrifugation, and bound p115 de-
tected by immunoblotting and quantitated. The results are ex- GM130 remains bound to Golgi membranes during
pressed as the mean of two experiments, with the error bar showing treatment with mitotic cytosol (Figure 6A, lane 3), so if
the range. it mediates the essential role played by p115 during
cisternal regrowth, it should be inhibited by the N-termi-
nal GM130 peptide. This is shown in Table 1. Cisternal
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Table 1. The Effect of N73pep on Cisternal Regrowth from Mitotic Golgi Fragments
Percent
Percent Cisternal Membrane
Incubation Peptide Pretreatmenta Regrowthb in Cisternaec
none 0 17 6 3
NSF none 100 38 6 4
NSF control none 83 6 5 34 6 5
NSF N73pep none 18 6 10 21 6 4
NSF N73pep interphase 10 6 3 19 6 5
NSF N73pep mitotic 83 6 8 34 6 8
p97 none 100 39 6 5
p97 N73pep none 85 6 5 36 6 5
Salt-washed mitotic Golgi fragments were incubated with the components indicated in the presence or absence of the N-terminal GM130
peptide (N73pep) or control peptide (p115.4). N73pep was added at a 50-fold molar excess over p115 (NSF experiments) or at the same
concentration (p97 experiments).
aIn some experiments, N73pep was pretreated with interphase or mitotic cytosol.
bCisternal regrowth was calculated from the percent membrane in cisternae (% MC) within each experiment by the following equation; results
are presented as the mean 6 SD.
(% cisternal regrowth) 5
(% MC after incubation with peptide) 2 (% MC before incubation)
(% MC after incubation without peptide) 2 (% MC before incubation)
3 100
cResults are presented as the mean of all experiments 6 SD.
regrowth in the absence of peptide was set to 100% A peptide comprising the first 74 amino acids efficiently
competed with GM130 for binding to p115 beads. Thewithin each experiment, and the results averaged across
peptide also competed with membrane-bound GM130experiments. The GM130 peptide at a 50-fold molar ex-
for p115, though the efficiency was less. A 50-fold ex-cess over p115 was inhibitory, reducing the percentage
cess of peptide over p115 inhibited binding to nativeregrowth to 18% 6 10%, whereas a control peptide
Golgi membranes by up to 70%, whereas a 17-fold ex-(p115.4) had little if any effect (83% 6 5%). Importantly,
cess had a similar effect indetergent extracts. This eitherpreincubation of the GM130 peptide with mitotic cytosol
suggests that the detergent conditions lower thebindingabolished its inhibitory effect (83% 6 8%), whereas pre-
affinity of GM130 for p115 or another protein, such asincubation with interphase cytosol did not (10% 6 3%).
the p400 protein (Figure 1), is involved in the binding toAs a final control, we exploited the fact that cisternae
native membranes. This will be resolved once p400 iswill also regrow from mitotic fragments in the presence
identified. Antibodies raised to the N-terminal peptideof another fusion protein, p97. This fusion protein does
confirmed the role played by the N-terminus of GM130.not need p115 for regrowth to occur (Rabouille et al.,
When used to pretreat Golgi membranes, the binding1995). As shown in Table 1, the GM130 peptide had little
of p115 was inhibited by about 60%.effect on p97-mediated cisternal regrowth (85% 6 5%).
These biochemical experiments were complementedThe results in Table 1 are also presented as the per-
by transient expression of GM130 constructs in vivo.centage membrane in cisternae averaged across all ex-
They all disrupted the Golgi localization of p115 but inperiments. The pattern of results is exactly the same
different ways. The N-terminal deletion constructs wereand also shows that the signal to noise of the assay is
unable to bind p115, so when they displaced the endog-in excess of 2:1.
enous GM130, p115 could no longer localize to the Golgi
apparatus. Conversely, the C-terminal deletion con-Discussion
structs could not bind to Golgi membranes and were
dispersed throughout the cytosol. Since they could bind
Several lines of evidence identify GM130 as a binding
to p115, they presumably competed effectively with en-
site for the vesicle docking protein p115. GM130 was dogenous GM130 for the available p115. Similar results
one of only two proteins in Triton-solubilized extracts of were obtained by microinjection of the N-terminal pep-
Golgi membranes that bound specifically to immobilized tide into the cytosol, strongly suggesting that it can also
p115. In vitro-transcribed and -translated GM130 recog- bind to p115 in vivo.
nized p115 in overlay blots of the pure protein and in The binding domain on GM130 for Golgi membranes
whole Golgi extracts. In the latter extracts, it also recog- was in the C-terminal half of the protein. Transient trans-
nized itself, consistent with earlier work suggesting that fection showed that constructs lacking this half (or more)
GM130 can form oligomeric complexes (Nakamura et of the protein were unable to bind to Golgi membranes
al., 1995). The converse experiment also worked with or compete with endogenous GM130 even when overex-
biotinylated p115, specifically recognizing GM130 in pressed. A construct comprising the C-terminal third of
whole Golgi extracts and immunopurified preparations. GM130 was able to do both, though binding to Golgi
The binding site for p115 appeared to be at the membranes was not as efficient as a construct compris-
N-terminus of GM130. Deletion of only 74 N-terminal ing the C-terminal half. This was able to bind as well as
amino acids abolished binding to p115 beads. C-termi- the full-length protein. The results suggest that the ac-
nal deletions showed that just over half of the protein tual binding domain is toward the C-terminus but bind-
ing is stabilized by other sequences in the C-terminalcould be removed with little effect on binding efficiency.
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half. Experiments are now in progress using C-terminal that the increase was only 1±2 kDa. It remains to be
sequences to identify the precise Golgi binding site for seen whether this represents additional phosphorylation
GM130. of other parts of the GM130 molecule and whether this
A direct homolog of GM130 has not been found in the has functional significance. Experiments are in progress
yeast genome database. Interestingly, the protein that using purified protein kinases to identify those responsi-
consistently gives the highest homology is Uso1p, the ble. It is interesting to note in this regard that the
homology residing in the tail region. Since the tail in N-terminal peptide has two putative cyclin-dependent
Uso1p is three times longer than that in p115 (Sap- kinase phosphorylation sites (boxed regions in Figure
perstein et al., 1995; Yamakawa et al., 1996), this raises 3A) (Songyang et al.,1994), which could serve to regulate
the interesting possibility that Uso1p is a fusion of p115 p115 binding. The binding of GM130 to Golgi mem-
and GM130. In other words, GM130 would represent branes is unlikely to be regulated, since mitotic phos-
the extra long tail found in Uso1p but not p115. The phorylation both in vivo (Nakamura et al., 1995) and in
combined molecular mass of p115 and GM130 (218 kDa) vitro (Figure 6A) did not release GM130 from the mem-
is certainly close to that of Uso1p (206 kDa). One would brane.
also expect that Uso1p could not be susceptible to the The functional significance of this mitotic regulation
type of mitotic regulation seen with p115 and GM130. was tested using a Golgi reassembly assay. Mitotic
This is consistent with the fact that membrane traffic Golgi fragments will reform cisternae in the presence of
through the yeast Golgi is not disrupted during mitosis, either NSF or p97. The NSF-dependent reassembly is
as it is in mammalian cells when the Golgi apparatus absolutely dependent on the presence of p115, and re-
fragments (Warren, 1993). This speculation would mean assembly was shown to be inhibited by the N-terminal
that the Golgi binding site for Uso1p should be the same GM130 peptide. The peptide limited cisternal regrowth
as that for GM130. It will therefore be important tosearch to 18% at a 50-fold molar excess over p115. The speci-
for Uso1p-binding proteins in yeast membrane extracts. ficity was confirmed using an irrelevant p115 peptide
It will also be necessary to analyze in more detail the and by the fact that the GM130 peptide had no effect
GM130 binding sites on p115. It is interesting that our on the p97 reassembly pathway. Most importantly, the
preliminary experiments (Figure 2B) show efficient bind- inhibition was only seen using the untreated peptide or
ing to a truncated p115 lacking about two-thirds of the one treated with interphase cytosol. Pretreatment of
globular head but containing the entire tail region.
the peptide with mitotic cytosol abolished its inhibitory
The binding of p115 toGM130 was shown tobe mitoti-
effect. These data provide strong evidence in vitro that
cally regulated. Preincubation of Golgi membranes with
the regrowth of Golgi cisternae is dependent on the
mitotic cytosol prevented the binding of detergent-solu-
interaction of p115 with GM130 through the N-terminal
bilized GM130 to p115 beads. Pretreatment of p115
region. Furthermore, the absence of this interaction un-
beads had no effect, consistent with earlier work show-
der mitotic conditions could help explain the observeding that the target of mitotic regulation was the p115
fragmentation of the Golgi apparatus through inhibitingbinding site, not p115 itself (Levine et al., 1996). The
the docking of transport vesicles with their target mem-effect was reversible upon subsequent incubation with
brane. Specifically, it could explain the COPI-dependentinterphase cytosol and prevented by prior treatment of
pathway of fragmentation (Warren et al., 1995).the mitotic cytosol with either the general kinase inhibi-
GM130 is enriched on cis-Golgi membranes (Naka-tor, staurosporine, or the specific CDK inhibitors, olo-
mura et al., 1995) and so could service incoming COPImoucine and roscovitine. Mitotic regulation could be
and COPII vesicles on the anterograde pathway, as wellmimicked by the N-terminal GM130 peptide. When pre-
as providing a staging post for retrograde COPI vesiclestreated with mitotic cytosol, the peptide was unable
on their way from the Golgi stack back to the ER (Bed-to prevent binding of p115 to native GM130 on Golgi
narek et al., 1996). Low levels of GM130 might even bemembranes. Inactivation of the mitotic cytosol with
present on trans-Golgi membranes to receive antero-staurosporine prevented this effect. Furthermore, when
grade COPI vesicles moving through the Golgi stackthe peptide was bound to beads and incubated with
(Malhotra et al., 1989; Rothman and Wieland, 1996).mitotic cytosol, subsequent binding of p115 was almost
There is, however, no evidence that GM130 is presentcompletely abolished, an effect prevented by prior treat-
on those regions of the ER set up to receive retrogradement of the cytosol with staurosporine. The inhibition
COPI vesicles. The possibility of another binding site isof p115 binding is likely a direct effect of mitotic modifi-
presently being tested by repeating the p115-bindingcation of the bound peptide, rather than an indirect one
experiments using detergent-solubilized ER mem-mediated by a component of mitotic cytosol that only
branes.binds to the mitotically modified peptide. The bound
peptide was the major protein in the mitotic incubation
(constituting about 2% of the total protein), and the Experimental Procedures
beads were thoroughly washed with 1 M salt before
incubation with p115. Molecular Cloning
The Marathon cDNA Amplification Kit (Clontech) was used to gener-Mitotic regulation of GM130 and the N-terminal pep-
ate new GM130 clones by 59 RACE (Nakamura et al., 1995), thetide resulted in characteristic changes in the level and
longest of which had a 69 bp extension. A partial cDNA fragmentpattern of phosphorylation. GM130 was only phosphory-
of p115 was isolated during screening for GM130 clones (Nakamura
lated significantly by mitotic, not interphase cytosol, et al., 1995) and corresponded to the C-terminal 354 amino acids
resulting in a reversible increase in apparent molecular (Sapperstein et al., 1995). It was expressed as a His-tagged protein
mass of about 5 kDa that was prevented by kinase inhibi- using pQE10 (Qiagen).
Truncated cDNA constructs of GM130 were generated by PCRtors. Similar effects were seen using the peptide except
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using appropriate oligonucleotide primers and cloned into pBSI Treatments with Mitotic and Interphase Cytosols
Cytosols (Stuart et al., 1993) were prepared without phosphataseIKS1, verified by sequencing, and translated in vitro (Nakamura et
al., 1995). For expression in vivo, the cDNAs were subcloned into inhibitors and desalted into MEB buffer immediately prior to use
(Rabouille et al., 1995). Typically, 40 mg Golgi membranes was mixedpCMUIV (Nilsson et al., 1989) and tagged at the N-terminus with
MPEQKLISEEDLPSMPLR (Myc epitope underlined). For construct with 2.5 mg cytosol supplemented with an ATP-regenerating system
in a final volume of 300 ml and warmed to 378C for 10 min in theDN690, the completecoding sequence of GFP (Cormack et al., 1996)
was cloned after the Myc epitope. presence or absence of inhibitors (see legends to Figures 6 and 7).
Mitotically treated membraneswere reverted by subsequent incuba-
tion for 10 min with interphase cytosol. Twenty-five micromolarsMicroinjection and Immunofluorescence Microscopy
staurosporine and 10 mM microcystin were added at the end toPlasmid DNA was microinjected into the nucleus of NRK cells for
prevent further changes in the phosphorylation state, and mem-low (20 mg/ml for 8 hr) or high (80 mg/ml for 4 hr) expression levels.
branes were reisolated by centrifugation at 100,000 3 g for 10 min.N73pep (5 mg/ml with Cascade blue-BSA as a marker) was microin-
N73pep (5 mg) or 2.5 ml N73pep beads were phosphorylated byjected into the cytoplasm, and the cells incubated for 1 hr. Cells
incubation with 250 mg cytosolic protein in 25 ml for 30 min at 378C.were processed for epifluorescence or confocal microscopy (Naka-
In some incubations, the ATP-regenerating system was replacedmura et al., 1995).
by [g-32P]ATP at 1 mCi/ml.
Coupling to Streptavidin Beads
Rat liver p115 (Levine et al., 1996) was biotinylated using NHS- Reassembly Assay
LC-biotin (Pierce) (10 mg p115/mg biotin) according to the manufac- Salt-washed mitotic Golgi fragments were incubated with NSF, a-
turers instructions. It was coupled to ``Ultralink'' streptavidin beads and g-SNAPs, and p115, or with p97 (Rabouille et al., 1995). In
(Pierce) (0.3 mg biotin-p115/ml) in HKT buffer (10 mM HEPES [pH competition experiments, p115 was preincubated for 30 min on ice
7.4], 100 mM KCl, 0.25% Triton X-100, 1 mM EDTA, 0.5 mM DTT) with a 50-fold molar excess of peptide. Where stated, N73pep was
for 2 hr at 48C. N73pep was synthesized with an N-terminal biotin preincubated with interphase or mitotic cytosol at 378C for 30 min.
group and incubated at 2 mg peptide/ml streptavidin beads. After Membranes were processed for EM and quantitated (Rabouille et
coupling, beads were blocked with 5 mg/ml soybean trypsin in- al., 1995).
hibitor.
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